[ad_1]
Mumbai:
The civic-run King Edward Memorial (KEM) Hospital in Mumbai in the present day started part II and III trials of the Oxford Covishield vaccine for COVID-19, an official stated.
The hospital, situated in Parel space, on Tuesday acquired the approval of the Maharashtra ethics committee for conducting the vaccine trials.
King Edward Memorial Hospital Dean Dr Hemant Deshmukh informed information company Press Trust of India that the hospital has began screening volunteers for the trials.
The medical facility can be conducting the trials on 100 volunteers, he stated.
The Mumbai-based BYL Nair Hospital, one other facility run by the Brihanmumbai Municipal Corporation, has additionally acquired approval for conducting trials of the vaccine.
Both the King Edward Memorial Hospital and BYL Nair Hospital can be conducting the trials collectively on over 200 volunteers, sources informed information company PTI.
As a part of the trials, volunteers who’re discovered destructive for coronavirus in each RT-PCR and antigen assessments can be given the vaccine, they stated.
Trials of the Oxford vaccine candidate are being carried out in Pune as nicely.
The Pune-based Serum Institute of India (SII) has partnered with British-Swedish pharma firm AstraZeneca for manufacturing the COVID-19 vaccine candidate, being developed by the University of Oxford, UK.
(Except for the headline, this story has not been edited by NDTV employees and is revealed from a syndicated feed.)
[ad_2]
Source hyperlink